Research study Program year 2022 Source: CMS Open Payments

Dose finding Trial in PPP Phase II

Research payments

$699,067

78 payments

Through program year 2022, $699,067 in research payments was reported against Dose finding Trial in PPP Phase II, across 78 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by: Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$56,991	11
2021	Research	$113,364	10
2020	Research	$467,740	30
2019	Research	$60,973	27

Breakdown

Who paid Research payments · program years 2019–2022

Boehringer Ingelheim Pharmaceuticals, Inc. $699,067 78 payments

Who received the money Research payments · program years 2019–2022

Univ Of Missouri Health Care Teaching hospital · MO $129,376 5 payments
Menter Dermatology Research Institute Organisation paid for research $79,943 5 payments
Washington University Organisation paid for research $54,137 3 payments
Skin Specialists PC Organisation paid for research $46,957 3 payments
University of Pittsburgh Physicians Organisation paid for research $46,003 3 payments
Virginia Clinical Research INC Organisation paid for research $43,339 6 payments
University Of Utah Organisation paid for research $38,356 3 payments
Total Skin And Beauty Dermatology Center Organisation paid for research $35,677 2 payments
Windsor Dermatology Pc Organisation paid for research $35,369 3 payments
U Of Utah Neuropsychiatric Institute Teaching hospital · UT $24,334 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.